BMRC
Bank of Marin Bancorp
BMRC has the edge over GS overall, supported by stronger valuation and stronger fundamentals.
GS
The Goldman Sachs Group, Inc.
GS's outlook is improving, though it still trails on the overall score.
BMRC Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
BMRC's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like BMRC.
GS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
GS's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like GS.
BMRC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 6.8x | $28.52 | — |
| Cheap | 8.8x | $37.00 | +30% |
| Forward | 11x | $28.52 | — |
| Fair | 14x | $57.55 | +102% |
| Expensive | 18x | $75.08 | +163% |
Historical ranges are pointers, not guarantees.
BMRC has the edge over GS in the historical PE scenario, which offers more potential upside but is not a forecast.
GS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.6x | $528 | -42% |
| Current | 13x | $914 | — |
| Forward | 13x | $914 | — |
| Fair | 14x | $940 | +2.9% |
| Expensive | 17x | $1,214 | +33% |
Historical ranges are pointers, not guarantees.
GS's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
BMRC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BMRC, with profitability improving.
GS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
GS has the edge over BMRC on the outlook, with more favorable valuation expectations.
BMRC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.50 | -41% |
| Q3 2026 | $4.22 | +581% |
| Q2 2026 | $4.07 | +847% |
| Q1 2026 | $2.96 | +$3.36 |
| Q4 2025 | $2.73 | +$3.25 |
| Q3 2025 | $0.62 | +$1.48 |
| Q2 2025 | $0.43 | +$1.24 |
| Q1 2025 | -$0.40 | -148% |
| Q4 2024 | -$0.52 | -142% |
BMRC's earnings per share have jumped to their highest in seven years: $4.22 over the past year, up from $0.62 the year before.
GS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $72.35 | +4% |
| Q3 2026 | $69.58 | +41% |
| Q2 2026 | $64.82 | +43% |
| Q1 2026 | $54.75 | +27% |
| Q4 2025 | $51.32 | +27% |
| Q3 2025 | $49.22 | +44% |
| Q2 2025 | $45.37 | +45% |
| Q1 2025 | $43.08 | +68% |
| Q4 2024 | $40.54 | +77% |
GS has the edge over BMRC on earnings, with more consistent year-over-year improvement.
BMRC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $35.1M | +13% |
| Q2 2026 | $34M | +230% |
| Q1 2026 | $34.1M | +23% |
| Q4 2025 | $79.3M | +183% |
| Q3 2025 | $30.9M | +14% |
| Q2 2025 | $10.3M | +181% |
| Q1 2025 | $27.8M | +9.3% |
| Q4 2024 | $28M | +33% |
BMRC has the edge over GS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 39% | +7.9 points |
| Q2 2026 | 37% | +146 points |
| Q1 2026 | 34% | +11 points |
| Q4 2025 | 59% | +25 points |
| Q3 2025 | 31% | +5.4 points |
| Q2 2025 | -109% | +830 points |
| Q1 2025 | 23% | +7.9 points |
| Q4 2024 | 34% | +33 points |
BMRC has the edge over GS on profitability, with a higher operating margin.
GS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7B | +23% |
| Q2 2026 | $20.3B | +39% |
| Q1 2026 | $17.2B | +14% |
| Q4 2025 | $13.5B | -3% |
| Q3 2025 | $15.2B | +20% |
| Q2 2025 | $14.6B | +15% |
| Q1 2025 | $15.1B | +6% |
| Q4 2024 | $13.9B | +23% |
GS's revenue is growing: $18.7B last quarter, up 23% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | +2 points |
| Q2 2026 | 42% | +8.1 points |
| Q1 2026 | 38% | +0.2 points |
| Q4 2025 | 44% | +5.6 points |
| Q3 2025 | 36% | +4.1 points |
| Q2 2025 | 34% | +3.2 points |
| Q1 2025 | 37% | +0.6 points |
| Q4 2024 | 38% | +18 points |
GS's operating margin was 37% last quarter, up 2 points from the same quarter a year ago.
BMRC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $16M | +33% |
| Q2 2026 | $11.8M | +68% |
| Q1 2026 | $921K | -80% |
| Q4 2025 | $13.2M | +25% |
| Q3 2025 | $12.1M | +24% |
| Q2 2025 | $7.1M | +111% |
| Q1 2025 | $4.6M | +11% |
| Q4 2024 | $10.6M | +1261% |
BMRC has the edge over GS on cash generation, producing positive trailing cash flow while its opponent burns cash.
GS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +72% |
| Q2 2026 | $5.6B | +7.8% |
| Q1 2026 | -$32.4B | +$5.3B |
| Q4 2025 | -$16.8B | -136% |
| Q3 2025 | $2.1B | +$40.6B |
| Q2 2025 | $5.2B | -6.8% |
| Q1 2025 | -$37.7B | -$9.2B |
| Q4 2024 | $46.2B | +$75.1B |
GS's free cash flow was −$40B over the past year, against $15.8B the year before. Free cash flow isn't a meaningful measure for financial services companies like GS.
BMRC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +49K shares |
| 1 year | +0.7% | +106K shares |
| 3 years | 0% | +4K shares |
| 5 years | +7% | +1M shares |
| Available history | +16% | +2.2M shares |
BMRC has 16M diluted shares, up 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $6,000 |
| Q1 2026 | $6,000 |
| Q4 2025 | — |
| Q3 2025 | $1.1M |
| Q4 2024 | $19,000 |
| Q2 2024 | $55,000 |
| Q4 2023 | — |
BMRC has spent almost nothing on buybacks in the past year.
GS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -3.8M shares |
| 1 year | -4.4% | -13.9M shares |
| 3 years | -12% | -42.8M shares |
| 5 years | -15% | -52.8M shares |
| Available history | -20% | -74.4M shares |
GS has the edge over BMRC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3B |
| Q2 2026 | $4B |
| Q1 2026 | $5B |
| Q4 2025 | $3B |
| Q3 2025 | $2B |
| Q2 2025 | $3B |
| Q1 2025 | $4.4B |
| Q4 2024 | $2B |
GS spent $15B buying back its own shares over the past year, up 32% from the year before.
BMRC Net Leverage
GS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.4x | Net Cash |
| Q2 2026 | -6.1x | Net Cash |
| Q1 2026 | -6.7x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2025 | -3.1x | Net Cash |
| Q1 2025 | -3.9x | Net Cash |
| Q4 2024 | -4.7x | Net Cash |
GS has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like GS.
BMRC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.3 | Neutral |
| Stochastic | 61.9 | Neutral |
BMRC's weekly RSI is 58 (neutral) and its Stochastic is 62 (neutral).
GS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 16.3 | Oversold |
GS's weekly RSI is 45 (neutral) and its Stochastic is 16 (oversold).
BMRC PE vs Financial Services Sector
| Metric | BMRC | Sector median | Relative |
|---|---|---|---|
| PE | 6.8x | 13x | 48% below |
| PE % | 6 | 63 | 57 pts below |
BMRC has the edge over GS on valuation relative to its sector.
GS PE vs Financial Services Sector
| Metric | GS | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.8% above |
| PE % | 46 | 63 | 17 pts below |
GS is trading at 13x earnings, in line with the Financial Services sector's median of 13x, though its earnings don't support one.
BMRC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.6 | 3.2% above |
| 20 week MA | $27.9 | 2.1% above |
| 50 week MA | $26.9 | 6.1% above |
| 100 week MA | $25.1 | 13% above |
| 200 week MA | $22.6 | 26% above |
BMRC has the edge over GS on trend strength, trading above more of its moving averages.
GS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $895.5 | 2% above |
| 20 week MA | $977.4 | 6.5% below |
| 50 week MA | $945.4 | 3.4% below |
| 100 week MA | $804.5 | 14% above |
| 200 week MA | $602.7 | 52% above |
GS's trend is mixed: it's above three of its five weekly moving averages, and 52% above its 200-week average.
BMRC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $46.0 | $36.5 | -21% |
| 2021 | $36.5 | $36.6 | +0.4% |
| 2022 | $36.6 | $33.0 | -9.9% |
| 2023 | $33.0 | $22.0 | -33% |
| 2024 | $22.0 | $23.5 | +6.8% |
| 2025 | $23.5 | $26.6 | +13% |
| 2026 YTD | $26.6 | $28.5 | +7.3% |
BMRC has the edge over GS on returns for 2026, with the stronger performance.
GS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $230.7 | $256.2 | +11% |
| 2021 | $256.2 | $385.0 | +50% |
| 2022 | $385.0 | $345.5 | -10% |
| 2023 | $345.5 | $385.8 | +12% |
| 2024 | $385.8 | $576.2 | +49% |
| 2025 | $576.2 | $907.0 | +57% |
| 2026 YTD | $907.0 | $913.6 | +0.7% |
GS has finished higher in five of the last six years, two of them by more than 50%. It's up 0.7% so far in 2026.